DJIA 16,931.63 19.34 0.11%
NASDAQ 4,759.21 -31.95 -0.67%
S&P 500 1,995.05 -0.78 -0.04%
market minute promo

7.51 -0.12 (-1.57%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACHN $7.51 -1.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.58
Previous Close $7.63
Daily Range $7.23 - $7.63
52-Week Range $6.41 - $16.87
Market Cap $1.0B
P/E Ratio -9.66
Dividend (Yield) $0.00 (0.0%)
Volume 1,015,583
Average Daily Volume 2,878,343
Current FY EPS -$0.38




Drug Makers


A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website:

News & Commentary

Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?

Four new late-stage studies from Gilead Sciences demonstrate that it's once again raised the bar in treating hepatitis C. Can anything stop Gilead?

Introduction To Dr De's Real-Time Biotech Stock Trade Alert Service

Achillion Pharmaceuticals (ACHN) Highlighted As Today's Perilous Reversal Stock

Premarket Biotech Digest: Jardiance Data, Eli Lilly Rallies, Regenxbio's Strong Debut

Gilead Provides An Update: Review And Analysis Of Wednesday's Q&A

Achillion Pharma Rises on Solid Interim Results

Can Achillion Pharmaceuticals (ACHN) Run Higher on Strong Earnings Estimate Revisions?

Does Achillion's 13% Slump in August Make It a Bargain?

Achillion is now valued at less than the potential milestones it may receive from Johnson & Johnson.

UBS: Biotech Will Continue To Outperform In 2015

Morning Market Gainers

See More ACHN News...

ACHN's Top Competitors

ACHN $7.51 (-1.57%)
Current stock: ACHN
AMGN $147.93 (-0.08%)
Current stock: AMGN
GILD $98.97 (-1.30%)
Current stock: GILD
BIIB $275.99 (-1.16%)
Current stock: BIIB